Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease (TELEX)

NCT02593110 NA COMPLETED Results posted

The TELEX trial will establish whether telmisartan alone improves walking performance in people with peripheral artery disease (PAD). The TELEX trial will also determine whether telmisartan plus supervised exercise improves walking performance more than either therapy alone. TELEX is a randomized controlled clinical trial (2 x 2 factorial design) of 112 participants with PAD randomized to one of four arms: Group A: telmisartan + supervised exercise therapy; Group B: telmisartan + a "no exercise" control group; Group C: placebo + supervised exercise therapy; and Group D: placebo + a "no exercise" control group.

Details

Lead sponsor	Northwestern University
Phase	NA
Status	COMPLETED
Enrolment	114
Start date	Mon Jan 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jun 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Peripheral Artery Disease

Interventions

• Supervised Treadmill Exercise Therapy
• Telmisartan
• "No exercise" control group
• Placebo

Countries

United States